Prostatype Genomics Net Margin

Net Profit Margin of Prostatype Genomics is -20,628.64 % in 2026.

Net Profit Margin of Prostatype Genomics changed from -3,055.68 % to -20,628.64 %, representing a 575.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Prostatype Genomics since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Prostatype Genomics with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.